<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04757818</url>
  </required_header>
  <id_info>
    <org_study_id>CPC COVID</org_study_id>
    <nct_id>NCT04757818</nct_id>
  </id_info>
  <brief_title>Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.</brief_title>
  <acronym>CPC COVID</acronym>
  <official_title>Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dentaid SL</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IrsiCaixa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dentaid SL</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Double-blind, parallel, randomized, placebo-controlled clinical study. Subjects with&#xD;
      confirmed SARS-CoV-2 infection by PCR or antigen rapid test, asymptomatic or with mild&#xD;
      COVID-19 symptoms will be included. Subjects who agree to participate and who are eligible&#xD;
      will be randomized to perform a mouth rinse and gargle with a 0.07% CPC mouthwash&#xD;
      (experimental) or with a substance of the same color (placebo). Saliva samples will be&#xD;
      collected at baseline (i.e., before wash) and 1 hour and 3 hours after wash. Saliva samples&#xD;
      will be transferred to a central laboratory for SARS-CoV-2 viral load determination,&#xD;
      nucleocapsid protein levels determination, rapid antigen testing, viral infectivity analysis&#xD;
      and storage.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study procedures will be as follows:&#xD;
&#xD;
      The study procedures will take place in 1 day (total interval of 3 hours from the baseline&#xD;
      sample collection to the last sample collection).&#xD;
&#xD;
      The study samples will be saliva samples (1-1.5 ml) collected at baseline and 1 and 3 hours&#xD;
      after the intervention. The intervention will be the use of a mouthwash (washes and gargles)&#xD;
      for one minute with 15 ml of either CPC Protect® (CPC group) or colored distilled water&#xD;
      (control group).&#xD;
&#xD;
      Candidates with a positive result of PCR or antigen rapid test for SARS-CoV-2 will be&#xD;
      identified by study nurses, certified nursing assistants, and dentists at primary health care&#xD;
      centers of the Metro Nord health administrative region of Catalonia. The investigator will&#xD;
      obtain the candidates' informed consent and will verify that the subject meets all the&#xD;
      inclusion criteria and none of the exclusion criteria. The researcher will assign a&#xD;
      correlative kit number (randomization) and instruct the subject in the procedure of&#xD;
      self-collection of a saliva sample.&#xD;
&#xD;
      Baseline: The subject will self-collect the baseline saliva sample in front of the&#xD;
      investigator, who will be able to correct the errors observed in the procedure.&#xD;
&#xD;
      Hour 0: After the obtention of the baseline saliva sample, the subject will rinse and gargle&#xD;
      with 15 mL of mouthwash (experimental or placebo) for 1 minute (30 seconds of rinsing and 30&#xD;
      seconds of gargling).&#xD;
&#xD;
      The researcher will indicate to the subject the hours in which the second and third saliva&#xD;
      samples should be taken. The subject must avoid brushing their teeth, eating and drinking,&#xD;
      except water, until the rest of the saliva samples are collected and may return home.&#xD;
&#xD;
      Hour 1: One hour after mouthwash use, the subject will self-collect the second saliva sample&#xD;
      (1-hour sample).&#xD;
&#xD;
      Hour 3: Three hours after mouthwash use, the subject will self-collect the third saliva&#xD;
      sample (3-hour sample).&#xD;
&#xD;
      The investigator will contact the subject to confirm the correct collection of saliva samples&#xD;
      (1 hour and 3 hours) at the indicated times and will record it in the study application.&#xD;
&#xD;
      Saliva samples will be collected at the center and/or at the subjects' residence and will be&#xD;
      transferred to the Clinical Laboratory Metropolitana Nord in Hospital Universitari Germans&#xD;
      Trias i Pujol (HUGTiP) for the viral load analysis by RT-PCR. The remaining saliva volume&#xD;
      will be transferred to IrsiCaixa's Laboratory (located in the HUGTiP) for the ELISA analysis&#xD;
      and the rest of the analysis, and for storage in those cases where the subject's IC is&#xD;
      available for it.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 17, 2021</start_date>
  <completion_date type="Actual">June 3, 2021</completion_date>
  <primary_completion_date type="Actual">May 25, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Double-blind, randomized, parallel, placebo-controlled clinical study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SARS-CoV-2 viral load in saliva samples measured by RT-qPCR</measure>
    <time_frame>1 hour and 3 hours after intervention</time_frame>
    <description>To determine the efficacy of a 0.07% CPC mouthwash in reducing the viral load of SARS-CoV-2 in saliva samples, measured by RT-qPCR, in subjects with confirmed SARS-CoV-2 infection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nucleocapsid protein levels in saliva samples measured by ELISA</measure>
    <time_frame>1 hour and 3 hours after intervention</time_frame>
    <description>To determine the efficacy of a 0.07% CPC mouthwash in increasing the nucleocapsid protein levels in saliva samples, measured by high-sensitivity quantitative ELISA (ImmunoDiagnostics), in subjects with confirmed SARS-CoV-2 infection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SARS-CoV-2 viral load in saliva samples determined by RT-qPCR</measure>
    <time_frame>1 hour after intervention</time_frame>
    <description>To determine the reduction of SARS-CoV-2 viral load by RT-qPCR in saliva samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SARS-CoV-2 viral load in saliva samples determined by RT-qPCR</measure>
    <time_frame>3 hours after intervention</time_frame>
    <description>To determine the reduction of SARS-CoV-2 viral load by RT-qPCR in saliva samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity of different rapid SARS-CoV-2 antigen tests compared to RT-qPCR in saliva samples</measure>
    <time_frame>1 hour and 3 hours after intervention</time_frame>
    <description>To compare the sensitivity and specificity of rapid SARS-CoV-2 antigen tests compared to RT-qPCR in saliva samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraindividual difference in SARS-CoV-2 infectivity in vitro before and after treatment with a 0.07% CPC or placebo</measure>
    <time_frame>Baseline, 1 hour and 3 hours after intervention</time_frame>
    <description>To determine the intraindividual difference in SARS-CoV-2 infectivity in vitro before and after treatment with a 0.07% CPC or placebo</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">118</enrollment>
  <condition>SARS-CoV-2 Infection</condition>
  <arm_group>
    <arm_group_label>0.07% cetylpyridinium chloride (CPC) in mouthwash</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose. A mouthwash and gargles with 15 ml of product for 1 minute.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Distilled water with the same colorant as the experimental product</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single dose. A mouthwash and gargles with 15 ml of product for 1 minute.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>0.07% cetylpyridinium chloride (CPC) in mouthwash</intervention_name>
    <description>A mouthwash and gargles with 15 ml of 0.07% cetylpyridinium chloride (CPC) in mouthwash for 1 minute.</description>
    <arm_group_label>0.07% cetylpyridinium chloride (CPC) in mouthwash</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Distilled water with the same colorant as the experimental product</intervention_name>
    <description>A mouthwash and gargles with 15 ml of distilled water for 1 minute</description>
    <arm_group_label>Distilled water with the same colorant as the experimental product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age equal to or greater than 18 years&#xD;
&#xD;
          2. 2. Confirmation of SARS-CoV-2 infection, determined by PCR or validated rapid antigen&#xD;
             test1 from a nasopharyngeal smear performed in ≤3 days.&#xD;
&#xD;
          3. Without symptoms of COVID-19 or with symptoms with ≤3 days of evolution&#xD;
&#xD;
          4. Cognitive and motor ability to perform mouthwashes and gargles&#xD;
&#xD;
          5. Willingness to comply with the requirements of the protocol&#xD;
&#xD;
          6. Understanding of the information provided in relation to the objectives and procedures&#xD;
&#xD;
          7. Provide your consent freely to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Use of mouthwashes, in the last 24 hours&#xD;
&#xD;
          2. Use of VITIS pastes and / or PERIO AID gel, in the last 24 hours&#xD;
&#xD;
          3. Four or more days of symptoms compatible with COVID-19.&#xD;
&#xD;
          4. Recent medical diagnosis (≤ 1 month) of pneumonia&#xD;
&#xD;
          5. Cognitive impairment or other reason that, in the investigator's discretion,&#xD;
             contraindicates participation in the study&#xD;
&#xD;
          6. Hyposialia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CAP Gorg</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08913</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Gran Sol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08914</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP St Roc</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08918</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Barri Llatí</name>
      <address>
        <city>Santa Coloma De Gramenet</city>
        <state>Barcelona</state>
        <zip>08921</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Fondo</name>
      <address>
        <city>Santa Coloma De Gramenet</city>
        <state>Barcelona</state>
        <zip>08923</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Santa Rosa</name>
      <address>
        <city>Santa Coloma De Gramenet</city>
        <state>Barcelona</state>
        <zip>08923</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Singuerlin</name>
      <address>
        <city>Santa Coloma De Gramenet</city>
        <state>Barcelona</state>
        <zip>08924</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Dr Robert</name>
      <address>
        <city>Badalona</city>
        <zip>08911</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Les Franqueses del Vallès</name>
      <address>
        <city>Bellavista</city>
        <zip>08521</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Canovelles/Granollers Oest</name>
      <address>
        <city>Canovelles</city>
        <zip>08420</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Granollers Centre</name>
      <address>
        <city>Granollers</city>
        <zip>08401</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ABS Gatassa</name>
      <address>
        <city>Mataró</city>
        <zip>08302</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EAP Mollet Est</name>
      <address>
        <city>Mollet Del Vallès</city>
        <zip>08470</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Montornés/Montmeló</name>
      <address>
        <city>Montornés del Vallès</city>
        <zip>08170</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Palau</name>
      <address>
        <city>Palau-solità i Plegamans</city>
        <zip>08184</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EAP Parets del Vallès</name>
      <address>
        <city>Parets del Vallès</city>
        <zip>08150</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Sant Celoni</name>
      <address>
        <city>Sant Celoni</city>
        <zip>08470</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAP Santa Perpètua</name>
      <address>
        <city>Santa Perpètua de Mogoda</city>
        <zip>08130</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EAP Vilassar de Mar</name>
      <address>
        <city>Vilassar de Mar</city>
        <zip>08340</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 16, 2021</study_first_submitted>
  <study_first_submitted_qc>February 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2021</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SARS-CoV-2</keyword>
  <keyword>Cetylpyridinium chloride</keyword>
  <keyword>COVID19</keyword>
  <keyword>Mouthwash</keyword>
  <keyword>Saliva sample</keyword>
  <keyword>RT-qPCR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cetylpyridinium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

